Overexpression of a New Gene p28GANK Confers Multidrug Resistance of Gastric Cancer Cells

REFERENCES

• Stavrovskaya A. A. Cellular mechanism of multidrug resistance to tumor cells. Biochemistry (Moscow) 2000; 65: 112–116
   Google Scholar
• Banerjee D., Mayer-Kuckuk P., Capiaux G., Budak-Alpdogan T., Gorlick R., Bertino J. R. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochimica Biophysics Acta 2002; 1587: 164–173
   PubMed Web of Science ®Google Scholar
• Larsen A. K., Escargueil A. E., Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85: 217–229
   PubMed Web of Science ®Google Scholar
• Ross D. D. Novel mechanisms of drug resistance in gastric cancer. Gastric Cancer 2000; 14: 467–473
   Google Scholar
• Liman T., Druley T. E., Stein W. D., Bates S. E. From MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001; 58: 931–959
   PubMed Web of Science ®Google Scholar
• Narasaki F., Oka M., Nakano R., Ikeda K., Fukuda M., Nakamura T., Soda H., Nakagawa M., Kuwano M., Kohno S. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric and colorectal cancer cells. Biochem Biophys Res Commun 1997; 240: 606–611
   PubMed Web of Science ®Google Scholar
• Nakamura T., Oka M., Aizawa K., Soda H., Fukuda M., Terashi K., Ikeda K., Mizuta Y., Noguchi Y., Kimura Y., Tsuruo T., Kohno S. Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells. Biochem Biophys Res Commun 1999; 255: 618–624
   PubMed Web of Science ®Google Scholar
• Tomonaga M., Oka M., Narasaki F., Fukuda M., Nakano R., Takatani H., Ikeda K., Terashi K., Matsuo I., Soda H., Cowan K. H., Kohno S. The multidrug resistance-associated protein gene confers drug resistance in human gastric and colon cancers. Jpn J Cancer Res 1996; 87: 1263–1270
   PubMedGoogle Scholar
• Johnstone R. W., Ruefli A. A., Lowe S. W. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002; 108: 153–164
   PubMed Web of Science ®Google Scholar
• Inoue S., Salah-Eldin A. E., Omoteyama K. Apoptosis and anticancer drug resistance. Hum Cell 2001; 14: 211–221
   PubMedGoogle Scholar
• Shibuya H., Kato Y., Saito M., Isobe T., Tsuboi R., Koga M., Toyota H., Mizuguchi J. Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of BCL-2 family proteins. Melanoma Res 2003; 13: 457–464
   PubMed Web of Science ®Google Scholar
• Grossman D., Altieri D. C. Drug resistance in melanoma: Mechanisms, apoptosis, and new potential therapeutic targets. Cancer Metastasis Rev 2001; 20: 3–11
   PubMed Web of Science ®Google Scholar
• Siddik Z. H. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265–7279
   PubMed Web of Science ®Google Scholar
• Salinas A. E., Wong M. G. Glutathione S-transferases—A review. Curr Med Chem 1999; 6: 279–309
   PubMed Web of Science ®Google Scholar
• Waxman D. J. Glutathione S-transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy—A review. Cancer Res 1990; 50: 6449–6454
   PubMed Web of Science ®Google Scholar
• Tew K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 4313–4320
   PubMed Web of Science ®Google Scholar
• Hori T., Kato S., Saeki M., DeMartino G. N., Slaughter C. A., Takeuchi J., Toh-e A., Tanaka K. cDNA cloning and functional analysis of p28(Nas6p) and p40.5(Nas7p), two novel regulatory subunits of the 26S proteasome. Gene 1998; 216: 113–122
   PubMed Web of Science ®Google Scholar
• Dawson S., Apcher S., Mee M., Higashitsuji H., Baker R., Uhle S., Dubiel W., Fujita J., Mayer R. J. Gankyrin: An ankyrin-repeat oncoprotein interacts with CDK4 kinase and the S6 ATPase of the 26S proteasome. J Biol Chem 2002; 277: 10893–10902
   PubMed Web of Science ®Google Scholar
• Nagao T., Higashitsuji H., Nonoguchi K., Sakurai T., Dawson S., Mayer R. J., Itoh K., Fujita J. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 2003; 278: 10668–10674
   PubMed Web of Science ®Google Scholar
• Park T. J., Kim H. S., Byun K. H., Jang J. J., Lee Y. S., Lim I. K. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: Induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. Mol Carcinog 2001; 30: 138–150
   PubMed Web of Science ®Google Scholar
• Li J., Tsai M. D. Novel insights into the INK4-CDK4/6-Rb pathway: Counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 2002; 41: 3977–3983
   PubMed Web of Science ®Google Scholar
• Fu X., Wang H., Tan L., Liu S., Cao H., Wu M. Over-expression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol 2002; 8: 638–643
   PubMed Web of Science ®Google Scholar
• Li H., Fu X., Chen Y., Hong Y., Tan Y., Cao H., Wu M., Wang H. Use of Adenovirus-delivered sirna to target oncoprotein p28GANK in hepatocellular carcinoma. Gastroenterology 2005; 128: 2029–2041
   PubMed Web of Science ®Google Scholar
• Hao Z., Li X., Qiao T., Du R., Hong L., Fan D. CIAPIN1 confers multidrug resistance by upregulating the expression of MDR-1 and MRP-1 in gastric cancer cells. Cancer Biol Ther. 2006; 5: 261–266
   PubMed Web of Science ®Google Scholar
• Ghalia A. A., Rabboh N. A., Shalakani A., Seada L., Khalifa A. Estimation of glutathione S-transferase and its k isoenzyme in tumor tissues and sera of patients with ovarian cancer. Anticancer Res 2000; 20: 1229–1235
   PubMed Web of Science ®Google Scholar
• Guo C., Ding J., Yao L., Sun L., Lin T., Song Y., Sun L., Fan D. Tumor suppressor gene Runx3 sensitizes gastric cancer cells to chemotherapeutic drugs by downregulating Bcl-2, MDR-1 and MRP-1. Int J Cancer 2005; 116: 155–160
   PubMed Web of Science ®Google Scholar
• Lazarova D. L., Bordonaro M., Sartorelli A. C. Transcriptional regulation of the vitamin D3 receptor gene by ZEB. Cell Growth Differ 2001; 12: 319–326
   PubMedGoogle Scholar
• Du J., Pan Y., Shi Y., Guo C., Jin X., Sun L., Liu N., Qiao T., Fan D. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR. Int J Cancer 2005; 113: 213–220
   PubMed Web of Science ®Google Scholar
• Perkins C. L., Fang G., Kim C. N., Bhalla K. N. The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 2000; 60: 1645–1653
   PubMed Web of Science ®Google Scholar
• Mi Q. W., Cui B. L., Silva G. L., Lantvit D., Lim B., Chai H. Y., et al. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res 2001; 61: 4030–4037
   PubMed Web of Science ®Google Scholar
• Wandel C., Kim R. B., Kajiji S., Guengerich F. P., Wilkinson G. R., Wood A. J. P-glycoprotein and cytochrome P-450 3A inhibition: Dissociation of inhibitory potencies. Cancer Res 1999; 59: 3944–3948
   PubMed Web of Science ®Google Scholar
• Agrawal M., Abraham J., Balis F. M., Edgerly M., Stein W. D., Bates S., Ojo T., Chen C. C. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res 2003; 9: 650–656
   PubMed Web of Science ®Google Scholar
• Naito M., Matsuba Y., Sato S., Hirata H., Tsuruo T. MS-209, a quinoline-type reversal agent, potentiates antitumor efficacy of docetaxel in multidrug-resistant solid tumor xenograft models. Clin Cancer Res 2002; 8: 582–588
   PubMed Web of Science ®Google Scholar
• Sinicrope F. A., Dudeja P. K., Bissonnette B. M., Safa A. R., Brasitus T. A. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J Biol Chem 1992; 15: 24995–25002
   Google Scholar
• Gaitanos T. N., Buey R. M., Díaz J. F., Northcote P. T., Teesdale-Spittle P., Andreu J. M., Miller J. H. Peloruside A does not bind to the taxoid site on h-tubulin and retains its activity in multidrug-resistant cell lines. Cancer Res 2004; 64: 5063–5067
   PubMed Web of Science ®Google Scholar
• Cabot M. C., Giuliano A. E., Han T. Y., Liu Y. Y. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res 1999; 59: 880–885
   PubMed Web of Science ®Google Scholar
• Labialle S., Gayet L., Marthinet E., Rigal D., Baggetto L. G. Transcriptional regulators of the human multidrug resistance 1 gene, recent views. Biochem Pharmacol 2002; 64: 943–948
   PubMed Web of Science ®Google Scholar
• Potocnik U., Glavac M. R., Golouh R., Glavac D. The role of Pglycoprotein (MDR1) polymorphisms and mutations in colorectal cancer. Pflugers Arch 2001; 442: 182–183
   PubMed Web of Science ®Google Scholar
• Ruiz-Gomez M. J., Souviron A., Martinez-Morillo M., Gil L. P-gp, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicines. J Physiol Biochem 2000; 56: 307–312
   PubMed Web of Science ®Google Scholar
• Bader P., Fuchs J., Wenderoth M., von Schweinitz D., Niethammer D., Beck J. F. Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with Adriamycin or CDDP. Anticancer Res 1998; 18: 3127–3132
   PubMed Web of Science ®Google Scholar
• Igney F. H., Krammer P. H. Death and anti-death: Tumor resistance to apoptosis. Nat Rev Cancer 2002; 2: 277–288
   PubMed Web of Science ®Google Scholar
• Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Reed J. C. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941–2953
   PubMed Web of Science ®Google Scholar